Compare Roivant Sciences Ltd. Common Shares (ROIV) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs State Street SPDR S&P Homebuilders ETF — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B), while State Street SPDR S&P Homebuilders ETF trades at $94.77 (market cap $1.49B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 16.6× State Street SPDR S&P Homebuilders ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 1 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| ROIV | XHB | |
|---|---|---|
Market Cap | $24.72B | $1.49B |
Volume | 6,279,442 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $41.81 | $121.36 |
52-Week Low | $16.04 | $94.86 |
Typical Hold Time | 1 Days | 33 Days |
Enterprise Value | $20.99B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XHB (SPDR S&P Homebuilders ETF) trades at $95.66, up 0.81% with a bearish technical signal from moving averages. The ETF faces headwinds from rising mortgage rates above 7% but shows potential as homebuilder valuations signal historical buying opportunities. Recent housing data shows mixed signals with new home sales rising 1.6% in June while existing home sales declined 2.4%.
The ETF presents a contrarian opportunity as battered homebuilder stocks may rebound if housing affordability improves. Key risks include persistent high mortgage rates and economic uncertainty. Institutional activity shows mixed signals with Greenland Capital's $17.33 million investment contrasting CoreCap's 99.3% position reduction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
